RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent, on behalf of the Health Services Director, to execute a Purchase Order with Arthrex, Inc in an amount not to exceed $900,000 to procure instruments, implants, and supplies for the orthopedic department for the period from April 1, 2022, through January 31, 2024.
FISCAL IMPACT:
This purchase order will result in expenditures of up to $900,000 and will be funded 100% by Hospital Enterprise Fund I revenues.
BACKGROUND:
Arthrex, Inc. is a global medical device company and leader in new product development and medical education in orthopedics. Arthrex provides instruments, implants, supplies and biologics that are necessary for arthroscopic surgeries for better outcomes for our patients. There are currently no other products on the market that can achieve the same surgical outcomes in the same amount of time and the same patient and surgeon satisfaction. By having a lower footprint, and an ease of use, surgery times are shortened, patients’ recovery times are shortened, and the risk of infections are decreased.
|